Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption

Puntos clave

• To evaluate the effectiveness of aldosterone synthase inhibitors in treating hypertension.
• Analysis of aldosterone synthase inhibitors
• Assessment of blood pressure reduction
• Consideration of cost and access barriers
• Aldosterone synthase inhibitors show robust blood pressure reductions
• Uncontrolled hypertension remains a widespread issue
• Potential challenges include cost and access affecting treatment adoption